INC Research Becomes First Global CRO to Offer Clinical Research Monitor Credential
(Thomson Reuters ONE) -
Externally validated program sets global standard for measuring
competence of clinical monitors
Raleigh, N.C., Sept. 9, 2013 - INC Research, a therapeutically focused global
clinical research organization (CRO) with a Trusted Process® for delivering
reliable results, today announced it is the first global CRO to implement the
Clinical Research Monitor Accreditation program, an internationally recognized
standard for competence in clinical research monitoring offered through the
International Academy of Clinical Research (IAoCR). The new Clinical
Credentialing program standardizes training of clinical research associates
(CRAs) and establishes INC Research as the first accredited training center in
the U.S.
"INC Research is committed to providing the best clinical development services
to our biopharmaceutical partners, including the most highly trained and
competent monitoring staff in the industry," said Alistair Macdonald, Chief
Operating Officer. "The Clinical Credential program will validate INC Research
monitors' capabilities against globally recognized best practices, including
recognition and reporting of adverse events, understanding regulatory processes,
preparing for successful site initiations and site visits and more. Customers
can therefore be confident the CRAs assigned to their studies are not only well
trained and field tested, but also that their skills have been certified against
an independent quality standard."
By ensuring its CRAs meet the Clinical Credentialing standard, INC is positioned
to reduce risks to patients and lower error rates thereby helping to accelerate
new treatments to market. Exceptional training and global recognition of skills
also is expected to help attract and retain top clinical research professionals.
Launched in direct response to the industry's growing demand for accreditation
of clinical research professionals, IAoCR's credentialing process focuses on
independent verification of an individual's ability to monitor clinical trials
effectively in real-life situations. INC Research will train its CRAs, beginning
with entry-level monitors, according to the new IAoCR program, a process
spanning two to three months including field tests.
"Competent monitors play an essential role in getting new treatments to market
faster while protecting the rights and wellbeing of patients involved in
clinical trials," said Jacqueline Johnson North, CEO of IAoCR. "That's why
offering programs that regulate and standardize training for CRAs is so
important. I commend INC Research for being the first global CRO to embrace this
program."
Founded in 2011, IAoCR is fast becoming the globally recognized standard for
accreditation of professionals working in the international clinical research
industry. IAoCR courses and accreditations are recognized by educational
institutes and employers globally and are mapped to international qualification
frameworks. Accreditations cover the depth and breadth of clinical research
competencies and provide a far more accurate prediction of performance than
simply years of experience.
About IAoCR
International Academy of Clinical Research (IAoCR) aims to bring accreditation
to clinical research professionals. The aim is to ensure that clinical research
trainers are knowledgeable and appropriately qualified and that all training
courses are focused on verification of competence. IAoCR was founded following
several years of consultation with industry leaders who highlighted a need for
recognized professional accreditations for clinical research monitors, project
managers and trainers; and accreditation of clinical research training courses.
IAoCR accreditations are mapped to various international qualifications
frameworks. They are quality assured by bodies regulated by Ofqual (Office for
Qualifications and Examinations Regulation), which is recognized within the
ISCED (International Standard of Education) framework produced by UNESCO (United
Nations Educational, Scientific and Cultural Organization).
For further press information or to arrange an interview with a spokesperson
from the IAoCR, please contact: Jo Henderson, PR Consultant - Tel: +44 (0)7870
634567 Email: jo.henderson(at)writewaypr.co.uk
For more information on IAoCR, visit www.iaocr.com, follow us at (at)iaocr or
telephone +44 (0)1628 784 906.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development programs
of the highest integrity. Pharmaceutical and biotechnology companies look to us
for a complete range of customized Phase I to IV programs in all therapeutic
areas and patient populations. Our Trusted Process® methodology and therapeutic
foresight lead customers to better-informed product development decisions, while
our solid site relationships are a critical success factor in delivering
clinical trial results on time and on budget. INC was ranked "Top CRO" by sites
worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey.
INC Research is headquartered in Raleigh, NC. For more information, please visit
www.incresearch.com or follow us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1728070]
Unternehmensinformation / Kurzprofil:
Datum: 09.09.2013 - 16:01 Uhr
Sprache: Deutsch
News-ID 294777
Anzahl Zeichen: 6377
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 155 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Becomes First Global CRO to Offer Clinical Research Monitor Credential"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
